Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Portable CT increases chance of stroke survival and recovery

Portable CT increases chance of stroke survival and recovery

December 02, 2008

CHICAGO - New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment. Results of the study, conducted at North Shore Medical Center (NSMC)-Salem Hospital in Salem, Mass., will be presented today at the annual meeting of the Radiological Society of North America (RSNA).

"The hospital's acquisition of a portable CT scanner facilitated more rapid assessment of acute stroke patients and is anticipated to increase the number of patients to whom thrombolytic therapy can be administered," said the study's lead author, David B. Weinreb, M.D., now a resident physician in the Department of Radiology at Hospital of Saint Raphael in New Haven, Conn.




According to the National Institute of Neurological Disorders and Stroke (NINDS), stroke is the third leading cause of death in the U.S., and more than 700,000 cases of stroke are diagnosed annually. The most common kind of stroke, ischemic stroke, occurs when a blood clot blocks a blood vessel in the brain. Such strokes can be treated with thrombolytic therapy using a drug called tPA that dissolves the blockage. However, the window of opportunity to safely administer the medication is generally considered to be just three hours. Also, it is important to determine that there is no bleeding in the brain before administering tPA. One out of six strokes is caused by bleeding rather than clotting.

"tPA is usually the only shot we have at clot-induced ischemic strokes," Dr. Weinreb said. "But it needs to be administered in a closely monitored situation, because the drug can have extremely adverse effects in those patients whose strokes are instead due to bleeds."

Before a patient receives tPA, a head CT must be performed to ensure there is no bleeding in the brain. NINDS recommends that patients who arrive in the emergency room (ER) with signs of acute stroke undergo CT imaging within 25 minutes.

For the study, Dr. Weinreb and colleagues began using a portable CT scanner to assess stroke patients in the ER of NSMC-Salem Hospital. During the month prior to the acquisition of the portable scanner and for a four-month period following its installation, researchers measured how much time elapsed between a physician order for a head CT and performance of the scan.

The availability of the CT scanner in the hospital's ER reduced the time between the order and exam from 34 minutes to 15 minutes, a reduction of 54 percent. Based on simulation modeling, the researchers estimated that this improvement would increase by 86 percent the number of stroke patients able to be treated with thrombolytic therapy within the three-hour window.

According to Dr. Weinreb, most stroke patients are taken to relatively small community hospitals where access to CT scanning may be limited. When a CT scanner is available, it is not always in proximity to the ER, making transportation of critically ill patients to the radiology department both difficult and time-consuming.

"A portable eight-slice CT can be easily added and used to accurately identify a head bleed in a stroke or trauma patient," Dr. Weinreb said. "This new technology is able to solve a very important problem for a community hospital, where the majority of stroke victims are being treated."

Radiological Society of North America



Related Thrombolytic Current Events and Thrombolytic News Articles Thrombolytic Current Events and Thrombolytic News RSS Thrombolytic Current Events and Thrombolytic News RSS
Stanford study recommends change in treating pulmonary embolisms
William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics.

Aspirin and similar drugs may be associated with brain microbleeds in older adults
Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain.

Rush University Medical Center Orthopedic Experts Examine Overhead Throwing Injuries
Baseball season is underway. With the pros, college and high school teams taking to the baseball diamonds and Little Leaguers soon to follow, orthopedic specialists at Rush University Medical Center are cautioning players to be aware of and take precautions against throwing injuries.

Patients who wake up with stroke may be candidates for clot-busters
Giving clot-busting drugs to patients who wake up with stroke symptoms appears to be as safe as giving it to those in the recommended three-hour window, according to researchers at The University of Texas Medical School at Houston.

Stroke therapy window might be extended past nine hours for some
Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms. The findings are published in the online edition of Radiology.

WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke
A study conducted by a team of stroke experts from West Virginia University Health Sciences Center demonstrates that CT (computed tomography) perfusion imaging - a technology which measures blood flow and is available to most hospitals - may dramatically improve fast and accurate stroke diagnosis, enabling physicians to provide more targeted care and helping avoid potentially life-threatening complications of "clot buster" therapy.

New research could save lives and millions of dollars
The Hunter Medical Research Institute (HMRI) Stroke Research Group has developed a system to fast track stroke treatment which could benefit thousands of Australian stroke patients and save millions of dollars annually.

Treatment window expanded
Patients can still benefit up to 4.5 hours after a stroke if a drug that dis-solves blood clots in the brain is administered. Thus far, three hours had been considered the useful limit for administering thrombolytic drugs.

New blood clot guidelines for pregnant women
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.

Avoiding Spleen Removal for Cooley's Anemia Sufferers
Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia.
More Thrombolytic Current Events and Thrombolytic News Articles
  Guidelines for thrombolytics need updating.(Cardiovascular Medicine): An article from: Internal Medicine News
by Christine Kilgore (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2005. The length of the article is 864 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Guidelines for thrombolytics need updating.(Cardiovascular Medicine)
Author: Christine Kilgore
Publication: Internal Medicine News (Magazine/Journal)
Date: January 15, 2005
Publisher: International Medical News Group
Volume: 38 Issue: 2 Page: 62(1)

Distributed by Thomson...

Nattokinase Plus (100 mg, 90 capsules)

Nattokinase Plus (100 mg, 90 capsules)
by Vesta Pharmaceuticals

In the 1980s, Dr. Hiroyuki Sumi at the University of Chicago isolated the circulation-promoting enzyme in natto and called it Nattokinase, meaning enzyme from natto. Research (including two small human trials) has shown Nattokinase supports healthy blood flow by assisting in the circulatory clearing system of the body. Specifically, Nattokinase supports the fibrinolytic clearing system in the body which is responsible for healthy circulation, by helping to break down fibrin protein deposits in the bloodstream to promote and enhance healthy blood flow.

Thrombolytic Therapy for Stroke

Thrombolytic Therapy for Stroke
by Patrick D. Lyden (Editor)

UCSD Stroke Center, San Diego, CA. A text for clinicians treating patients in the first few hours after a stroke, providing all of the data necessary to understand the limitations of thrombolytic therapy. Includes protocols and case tutorials introducing the indications and contraindications of this type of therapy. DNLM: Cerebrovascular Accident--drug therapy.

  Thrombolytic Therapy in the Treatment of Mi [VHS]
Starring: Health and Sciences Television Network



Thrombolytic Therapy for Acute Stroke (Current Clinical Neurology)

Thrombolytic Therapy for Acute Stroke (Current Clinical Neurology)
by Patrick D. Lyden (Editor)

This extensively revised and expanded second edition incorporates the knowledge gained from the widespread implementation of large rt-PA for acute stroke trials and demonstrates the power of the new technologies now available. The authors have included much new material on stroke-MRI and computed omogaraphy, and updated all chapters describing the background, use, and nuances of thrombolytic therapy. They present everything one needs to know for proper patient selection, the key to successful treatment. Practical how-to chapters guide the reader in treating acute stroke patients, both with and without thrombolytic therapy. New detailed practice cases that simulate making the rounds in a world-class stroke center prepare practitioners to be as ready as possible for their first case.

Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine)

Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine)
by Shaker A. Mousa (Editor)

Albany College of Pharmacy, New York. Highlights the latest developments in antithrombotics and provides experimental methods for the discovery of new and improved anticoagulants. Presents relevant in vitro and in vivo models in thrombosis and hemostasis. For researchers and clinicians. DNLM: Anticoagulants--therapeutic use.

  Review of Thrombolytic Therapy and Thromboembolic Disease
by William R. Bell (Editor), Arthur A. Sasahara (Editor), Tim Phelps (Editor)



  Proceedings of the Conference on Thrombolytic Agents (April 8-9, 1960)
by Harold R. Roberts (Editor), J. Dieter Geratz (Editor)

Proceedings of the conference held April 8-9, 1960, in Chicago, Illinois. Sponsored by the Hematology Study Section, Public Health Service.

  Thrombolytic Therapy In Acute Ischemic S
by Takenori Yamaguchi (Author)



  Thrombolytic Therapy in Acute Ischemic Stroke II
by Gregory J. Del Zoppo (Author), Etsuro Mori (Author), Werner Hacke (Editor)



© 2009 BrightSurf.com